The $360 Billion Women’s Health Market: A 20-Year Misunderstanding

The women’s health market, particularly around menopause, has been overlooked for 20 years. Valued at $360 billion, this sector has been ignored despite impacting half the world’s population. However, the tide is turning with high-profile endorsements from celebrities like Naomi Watts, startup innovations from companies such as Stripes and Midi Health, and investment interest from firms like Amboy Street Ventures. The FDA’s recent rollback of long-standing warnings on hormone replacement therapy has further accelerated this shift. Yet, as the category grows, so does the challenge for women to distinguish evidence-based care from unproven wellness products and marketing hype. This evolution presents both opportunities and risks for the healthcare industry and investors alike.